OmniAb (OABI) Cash from Financing Activities (2021 - 2025)

OmniAb's (OABI) quarterly Cash from Financing Activities came in at -$50000.0 in Q4 2025, down 101.3% year-on-year from $3.8 million in Q4 2024, and down 100.18% on a QoQ basis from $27.7 million in Q3 2025.

OmniAb (OABI) Cash from Financing Activities (2021 - 2025) Analysis & Trends

OmniAb (OABI) has 5 years of Cash from Financing Activities data on file, last reported at -$50000.0 in Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 101.3% year-over-year to -$50000.0 in Q4 2025; TTM through Mar 2026 was $27.9 million, a 110.07% increase from a year earlier, with the FY2025 full-year figure at $27.9 million, up 114.39% from the prior year.
  • Cash from Financing Activities for Q4 2025 stood at -$50000.0, down from $27.7 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for OABI reached as high as $237.0 million in Q3 2021 and fell as low as -$227.4 million in Q4 2021.
  • Historically, Cash from Financing Activities has averaged $8.9 million across 5 years, with a median of $357000.0 in 2023.
  • Across the five-year window, Cash from Financing Activities soared 4912.28% in 2024 and plunged 101.3% in 2025, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$227.4 million in 2021, then surged by 144.5% to $101.2 million in 2022, then sank by 100.49% to -$496000.0 in 2023, then jumped by 876.01% to $3.8 million in 2024, then sank by 101.3% to -$50000.0 in 2025.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$50000.0 in Q4 2025, $27.7 million in Q3 2025, and $236000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -50,000.00
Dec 31, 2025 -50,000.00
Sep 30, 2025 27.68 Mn
Sep 30, 2025 27.68 Mn
Jun 30, 2025 236,000.00
Jun 30, 2025 236,000.00
Mar 31, 2025 44,000.00
Mar 31, 2025 44,000.00
Dec 31, 2024 3.85 Mn
Dec 31, 2024 3.85 Mn
Sep 30, 2024 8.57 Mn
Sep 30, 2024 8.57 Mn
Jun 30, 2024 803,000.00
Jun 30, 2024 803,000.00
Mar 31, 2024 -203,000.00
Mar 31, 2024 -203,000.00
Dec 31, 2023 -496,000.00
Dec 31, 2023 -496,000.00
Sep 30, 2023 171,000.00
Sep 30, 2023 171,000.00